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Abstract
A structure-activity relationship study of berberine and structurally related
compounds is reported. Berberine, was chemically modified in order to obtain canadine
and oxyberberine. The in vitro evaluation of antifungal activity of berberine, canadine,
oxyberberine, liriodenine, o-methyl-mostachatoline and other four derivatives is also
reported here. Our results allow us to determine the minimal structural requirements to
produce the antifungal response and can provide a guide for the design of new compounds
with these properties.
Resumen
Se presenta un estudio de correlación estructura-actividad de berberina y compuestos
estructuralmente relacionados. Se modifico químicamente la berberina con el objeto de
obtener canadina y oxiberberina. Se informa también la actividad antifúngica in vitro de
bereberina, canadina, oxyberberina, liriodenina, o-metil-mostachatolina y otros cuatro
derivados. Nuestros resultados nos han permitido determinar los mínimos requerimientos
estructurales para producir la respuesta antifúngica y pueden dar una guía para el diseño
de nuevos compuestos con estas propiedades.
Introduction
In the southern regions of Argentina (Patagonia), there are about sixteen different species
of Berberis (Berberidaceae) commonly know as “calafate” or “michay”. These plants are
representative of this geographical zone and can vary in size from small shrubs to small trees.
Although some reports [1-4] indicate that other species of Berberis have been used as a
remedy for different diseases, it appears that, at least in the south of Argentina, these plants had
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not really been used with therapeutical purposes. First-hand interviews with local Indian
communities in the state of Chubut (Argentina) indicate that the Indian people do not use “Calafate”
as remedy,  they use the roots only as a dye [5].
Figure 1 –structures of alkaloids reported here and of structurally related compounds.
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Recently, we have reported that the aqueous extracts of B.heterophylla do not possess
significant antimicrobial activity [6]. In addition the agar dilution method showed that none of the
aqueous extracts tested displayed significant antifungal activity against dermatophytes fungi. These
results account for, at least in part, the reason the Indian people of Patagonia do not use infusions
of Berberis heterophylla for therapeutically. In contrast to those results, berberine (compound I
in Figure 1) isolated from B. heterophylla displayed a moderate but significant antibacterial and
antifungal activity against Staphylococcus aureus and different Candida spp. Also we evaluated
berberine against a panel of Candida spp obtained from the clinical isolated.  It is interesting to
note that berberine displayed antifungal activity not only against standardized strains, but against
clinical isolated of Candidas. We tested it against 7 clinical strains from different body humors
from different immunocompromised patients. MIC (minimum inhibitory concentration) values
ranged from >128 to 16 μg/ml were obtained for berberine indicating a moderate but significant
activity against C. glabrata, C. albicans, C. lusitaniae, C. krusei and C. Parapsilosis [7].
A large number of studies have been performed in order to shed some light on the structural
aspects and bioactivities of berberine and its congeners. However, compared with these aspects,
the action mechanism of these alkaloids, at least at molecular level, has received relatively little
attention. In this regard, previously we performed a computer-assisted study reporting the
importance of aromatization within the putative bio-medical action mechanism of berberine and
related cationic alkaloids with double iso-quinolinoid skeleton [8]. In this supposed mechanism
of action of berberine, to prevent DNA replication, the first step is aromatization. In contrast to
the covalent dehydrogenation, which is endothermic, the aromatization under ionic conditions
was found to be exothermic [9]. Our results indicated that in the aromatization process the ease
of hydride ion removal parallels the stabilization energy of the aromatic compounds to be formed.
Comparing the nucleophylic additions to the pi-systems, LUMO (Lowest-Unoccupied-Molecular-
Orbital) energy values suggested a greater accessibility of the N(+) heterocycles in comparison
to the polycicle aromatic hydrocarbons. Thus, it appears that the quaternary nitrogen and the
aromatic polycyclic and planar structure of berberine is the pharmacophoric pattern to produce
the antifungal effect in this alkaloid.
With the aim to finding an experimental support for the above hypothesis, we report here
the obtention of some analogues of berberine, their antifungal effects as well as the structure-
activity relationship study performed on these alkaloids acting as antifugal compounds.
Experimental section
Chemistry
Canadine (compound II in Table 1)
Berberine chloride (105 mg) was dissolved in aqueous acetic acid 66.6 % (9 ml),  Zn
powder was added (10.54 g) with an aqueous HCl solution 35% (23 mL). The solution was
refluxed for 2 h at 100 ºC, when TLC indicated a complete reaction. The reaction mixture was
neutralized with an aqueous HONH4 30% (20 mL). It was extracted with CH2Cl2 (3 x 15 mL).
The combined CH2Cl2 extracts were dried, filtered, and evaporated to yield Canadine (65.4
mg). Canadine was purified by column chromatography and then identified by 1H and 13C NMR
and compared with spectral data from literature [10].
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Oxyberberine (XIII)
Table 1. MICs (¼g/ml) obtained for the different compounds.
Active values are denoted in bold.
Compounds A B C D E F G
I* 64 32 32 16 128 128 64
II >128 >128 >128 >128 >128 >128 >128
III >128 >128 >128 >128 >128 >128 >128
IV >128 128 64 128 128 >128 128
V >128 128 64 128 128 >128 128
XIII >128 >128 >128 >128 >128 >128 >128
XIV >128 >128 >128 >128 >128 >128 >128
XV >128 >128 >128 >128 >128 >128 >128
XVI >128 128 128 128 128 >128 128
A) C. albicans (00-604); B) C. glabrata; C) C. lusitaniae; D) C. krusei;
E) C. parapsilosis (951706); F) C. albicans (00-622); G) C. parapsilosis (00-629).
* Taken from reference 7
Berberine chloride (50 mg, 0.134 mmol) was dissolved in 20 % aqueous KOH (20 mL).
The solution was refluxed for 6 h at 80 ºC, when TLC indicated complete reaction. The reaction








 extracts were dried,
filtered, and evaporated to yield oxyberberine (46.5 mg, 98.5%). The oxyberberine was purified
by column chromatography and then identified by 1H and 13C NMR and compared with the
spectral data from literature[11].
Compounds III (see reference [12]) IV and V [13]; and the oxoaporphines XIV, XV
and XVI (reference [14]) have been previously reported and were kindly provided by Professor
Dr. D. Cortes-Martinez (Universidad de Valencia, España).
Biological assays
Microorganism and media
The microorganisms used for the fungistatic evaluation were obtained from the Department
of Mycology INEI ANLIS “Dr. Carlos G. Malbrán” Bs.As. Argentina: Candida albicans 00-
604 (soft bone), Candida glabrata 00-547 (hisopado), Candida haemulonii 982822,1
(hemocultive), Candida lusitaniae 00-623 (BAL) and Candida parapsilosis 00-629 (cirugy
injury) were used. All of them from clinical isolated.
 Antifungal assays
The antifungal activity was evaluated using the microdilution technique in media RPMI
1640. These bioassays were performed following references [15 –17].
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Results and Discussion
As was previously mentioned, in the putative mechanism of action for berberine to prevent
DNA replication, the first step is aromatization. With the aim to finding an experimental support
for the above hypothesis, as a first step of our study we obtain canadine (compound [II] in
Figure 1) from berberine. Canadine was inactive against all the fungi tested here (Table 1). It
should be noted that there are few structural differences between berberine and canadine. The
nitrogen atom is not quaternary in canadine, besides one of the rings is not aromatic in this
alkaloid (compare structures (I) and (II), Figure 1). At this stage of our study we assume that the
electronic effects appear to be more important than conformational factors in the production of
the antifungal response. Next we evaluate three compounds structurally related to berberine and
canadine. They are compounds III, IV and V. These molecules were kindly provided by Professor
Diego Cortes-Martinez (University of Valencia, Spain). It should be noted that these compounds
were chosen considering their different molecular flexibility. Compounds IV and V are
conformationally restricted due to the presence of a double bond in the connecting chain. In
addition these molecules possess a NCOCH3 moiety. None of these compounds displayed
significant antifungal activity (Table 1). These results provide additional support for the hypothesis
suggesting that the quaternary nitrogen, the aromatic polycyclic and the planar structure of berberine
is the pharmacophoric pattern to produce the antifungal effect of these alkaloids.
Alkaloids possessing a carbonyl group
Evaluation of the antifungal activity of onychine [VI], an azafluorene alkaloid, showed it to
have anticandidal (MIC of 3.12 μg/ml) and anticryptococcal (MIC of 3.12 μg/ml) activities [18-
19]. Subsequent structure-activity relationship studies revealed that the carbonyl moiety plays a
key role in the activity of these compounds. Thus, partial reduction of the carbonyl moiety led to
inactive dihydroonycine (VII). Evaluation of the chlorinated isomeric agents (VIII -X), revealed
that modification of the 4-methyl group to a chloromethyl moiety enhanced as well as broadened
the antifungal profile of azafluorenones [20-22]. In the last two decades some structurally related
and biologically active polycyclic aromatic alkaloids were isolated or re-synthesized [23,24].
Several of these were evaluated for antifungal activity. Among these, sampagine [XI] has an EC50
(median effective concentration) of 1.6 μg/ml against C. albicans [23] and zones of inhibition of
25-31 nm against C. albicans, C. glabatra and C tropicalis. which are comparable to
ketoconazole. Sampagine also showed potent activity against C. Neoformans and A. Fumigatus.
Other polyaromatic structures were evaluated for their antifungal activity. Meridine (XII) has
been reported to inhibit the growth of C. Albicans, C neoformans by interacting with nucleic
acid biosynthesis [25].
 Berberine was modified in order to obtain a polyaromatic derivative possessing a carbonyl
group, oxyberberine (XIII). Unfortunately  oxyberberine was inactive against all the fungi tested
(see Table 1).
In parallel we evaluate the oxoaporphines liriodenine (XIV), o-methyl-mostachatoline (XV)
and compound XVI, [14,26], all alkaloids possessing a carbonyl group in their structures and
structurally related to oxiberberine. These compounds showed marginal or null antifungal activity.
Thus, compound XVI only displayed a moderate antifungal effect (MIC=128 μg/ml); whereas
compounds XIV and XV were inactive (Table 1).
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Berberine isolated from B. Heterophylla displayed an interesting in vitro/in vivo antifungal
activity against a panel of pathogenic fungi [6,7] In addition berberine displayed a lower toxic
effect in comparison with ketoconazole. Unfortunately all the compounds tested here were inactive
or at least displayed lower antifungal activity than those reported for berberine. On the basis of
our results it appears that berberine is the best starting structure to look for new cationic alkaloids
with double isoquinolinoid skeleton acting as antifungal agents.
Conclusions
Previously we have reported the importance of aromatization within the putative bio-medical
action mechanism of berberine and related cationic alkaloids with double iso-quinolinoid skeleton.
It appears that the quaternary nitrogen and the aromatic polyciclic and planar structure of berberine
could be the pharmacophoric pattern for these alkaloids acting as antifungal agents. All the
compounds tested and reported here give an additional support for this hypothesis.
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